Showing results (1301-1310 of 3,182) with videos related to

Sort By:
Pageof 319
Translational Oncology|July 21, 2025
Global, regional, and national estimates of burden and risk factors of female cancers in child-bearing age: A systematic analysis for Global Burden of Disease Study and Bayesian projection to 2030Guang Chen, Shichen Zhou, Qiaoxin Shi, et al.
Translational Oncology|July 18, 2025
Epigenetic insights: unveiling the impact of hypomethylated CACNA2D3 and FLNA genes in breast cancer progressionSamar Sindi, Safiah Alhazmi, Mansour Alsaleem, et al.
Translational Oncology|July 2, 2025
Pterostilbene induces pyroptosis in mouse breast cancer cells through the caspase-3/Gasdermin E signaling pathway and reshapes the tumor immune microenvironmentXiaoxia Huang, Wenhui Yang, Xinyi Hu, et al.
Translational Oncology|July 23, 2025
AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progressionJuan Zhang, Biyang Jing, Xiaojian Ni, et al.
Translational Oncology|June 29, 2025
Machine learning-guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistanceXianfei Zhang, Zhengxin Yin, Xueyu Chen, et al.
Translational Oncology|June 25, 2025
miR-23b is a negative regulator of tumor suppressing PTPRG in colorectal cancerHong Duan, Jianhu Jia, Tingting Wang, et al.
Translational Oncology|December 17, 2025
Exploration of precise classification and therapeutic targets of breast cancer based on genes related to neuro-cancer crosstalkZhi Li, Chang Sun, Yangyang Cui, et al.
Translational Oncology|December 20, 2025
Diagnostic and prognostic value of EphB2 in nasopharyngeal carcinomaQiao Huang, Tao Hou, Yi Ren, et al.
Translational Oncology|December 18, 2025
The stem cell atlas of lung adenocarcinoma: A stemness blueprint for prognosis and immunotherapy successJiacheng Yin, Xing Jin, Zhengyang Hu, et al.
Translational Oncology|December 13, 2025
GATAD2B promotes ovarian cancer malignant progression via MYC/CD47 AxisTing Guo, Dengyun Nie, Jie Xu, et al.
Pageof 319